Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Mesoblast Ltd has a consensus price target of $8.17 based on the ratings of 6 analysts. The high is $12 issued by Maxim Group on September 24, 2024. The low is $1.5 issued by Chardan Capital on August 4, 2023. The 3 most-recent analyst ratings were released by Maxim Group, Piper Sandler, and Cantor Fitzgerald on September 24, 2024, July 23, 2024, and September 21, 2023, respectively. With an average price target of $13.33 between Maxim Group, Piper Sandler, and Cantor Fitzgerald, there's an implied 15.74% upside for Mesoblast Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Mesoblast (NASDAQ:MESO) was reported by Maxim Group on September 24, 2024. The analyst firm set a price target for $12.00 expecting MESO to rise to within 12 months (a possible 4.17% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Mesoblast (NASDAQ:MESO) was provided by Maxim Group, and Mesoblast upgraded their buy rating.
The last upgrade for Mesoblast Ltd happened on September 24, 2024 when Maxim Group raised their price target to $12. Maxim Group previously had a hold for Mesoblast Ltd.
The last downgrade for Mesoblast Ltd happened on August 7, 2023 when Maxim Group changed their price target from N/A to N/A for Mesoblast Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mesoblast, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mesoblast was filed on September 24, 2024 so you should expect the next rating to be made available sometime around September 24, 2025.
While ratings are subjective and will change, the latest Mesoblast (MESO) rating was a upgraded with a price target of $0.00 to $12.00. The current price Mesoblast (MESO) is trading at is $11.52, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.